Biggest News Aggregation in the World
📰 Evant Keller News

Evant Keller News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Evant Keller. Real-time updates on events, politics, business and more.

Spexis' CXCR4 inhibitor balixafortide demonstrates synergistic efficacy in combination with docetaxe

Spexis AG / Key word(s): Research UpdateSpexis' CXCR4 inhibitor balixafortide demonstrates synergistic efficacy in combination with docetaxel in a metastatic prostate cancer preclinical model 07.07.2022 / 07:30 Allschwil, Switzerland, July 7, 2022Spexis' CXCR4 inhibitor balixafortide demonstrates synergistic eff...
Switzerland General United States Evant Keller School Of Medicine Swiss Exchange University Of Michigan

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science